Personal tools
Log in

Skip to content. | Skip to navigation

Sections
You are here: Home About G-I-N Trustees Bio Previous Trustees Safia Qureshi, PhD
Document Actions
Search
Documents in the library
Venous thromboembolism and hor...

AHRQ (US) - Agency for Healthcare Research and Quality

Venous thromboembolism and hormone replacement therapy. Royal College of Obstetricians and Gynaecologists. NGC:008804

Status:
Published
Date of publication:
May 01, 2011
The use of anti-D immunoglobul...

AHRQ (US) - Agency for Healthcare Research and Quality

The use of anti-D immunoglobulin for rhesus D prophylaxis. Royal College of Obstetricians and Gynaecologists. NGC:008803

Status:
Published
Date of publication:
Mar 01, 2011
The management of vulval skin ...

AHRQ (US) - Agency for Healthcare Research and Quality

The management of vulval skin disorders. Royal College of Obstetricians and Gynaecologists. NGC:008799

Status:
Published
Date of publication:
Feb 01, 2011
The investigation and treatmen...

AHRQ (US) - Agency for Healthcare Research and Quality

The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage. Royal College of Obstetricians and Gynaecologists. NGC:008798

Status:
Published
Date of publication:
Apr 01, 2011
Pregnancy and breast cancer. R...

AHRQ (US) - Agency for Healthcare Research and Quality

Pregnancy and breast cancer. Royal College of Obstetricians and Gynaecologists. NGC:008801

Status:
Published
Date of publication:
Mar 01, 2011
More guidelines
 

Safia Qureshi, PhD

Member of the G-I-N Board of Trustees 2008/2009 and 2009/2010

Safia Qureshi October 2008Safia Qureshi is the Programme Director at the Scottish Intercollegiate Guidelines Network (SIGN).

At SIGN, Safia has responsibility for the guideline development and review programme, and is part of SIGN’s editorial team. Safia has practical experience of numerous methodological issues that will be familiar to international guideline development colleagues, for example: coordinated collaboration with other guideline developers, how to lift patient involvement beyond tokenism, using consensus methods when the evidence is limited and how to shorten the guideline development process.

With SIGN, Safia has nearly 10 years experience of international collaboration. She was a member of the AGREE Collaboration and was a member of the founding board of G-I-N. She is currently one of the editors of enGINe, the G-I-N newsletter. Safia has just completed a two terms as the Deputy Chair of the Network Steering Committee of CoCanCPG, a consortium of 17 partners from 11 countries, involved in Cancer Guidelines development, with the common goal of developing sustainable cooperation. Much of her experience from CoCanCPG is directly applicable to G-I-N.

My vision for G-I-N;
My first experience of working with other guideline developers at an international level was with the AGREE Collaboration. From the very first meeting I saw how empowering and invigorating it could be to share ideas, frustrations, hopes and ambitions with like-minded colleagues who could listen, empathise, and more often than not, enlighten. I see G-I-N as a facilitator, a supporter, a motivator, but most of all, always enthusiastic about guidelines.

Email: safia.qureshi@nhs.net

Page last updated: Oct 13, 2010

Bookmark & Share:

  • Facebook
  • Google Bookmarks
  • Twitter

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.